Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIA Trial: Tretinoin and Pioglitazone HCL Combination Therapy in Amyotrophic Lateral Sclerosis

NCT00919555 is registered in ClinicalTrials.gov with Phoenix Neurological Associates, LTD as lead sponsor.

NCT NCT00919555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00919555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIA Trial: Tretinoin and Pioglitazone HCL Combination Therapy in Amyotrophic Lateral Sclerosis
Lead sponsor
Phoenix Neurological Associates, LTD
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2012
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis